Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-26

Clinical Trial Update: Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours [Phase 2]

View source ↗

Summary

This Phase 2 trial update notes the completion of studies evaluating temozolomide in combination with topotecan for refractory and relapsed pediatric solid tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temozolomide (Temozolomide)
  • Topotecan (topotecan)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Neuroblastoma, Brain Tumors | Phase 2 | Status: COMPLETED